Abstract
The role of two important tumour suppressor genes, p16 and p53, was evaluated in cartilaginous tumour tissues. Genomic DNA from 22 chondrosarcomas, 5 benign chondroid tumours, 1 sample of reactive proliferative cartilage and 2 samples of normal cartilage were analysed using polymerase chain reaction, single strand conformational polymorphism, DNA sequencing and methylation-specific polymerase chain reaction. The p16 gene was found to be partly methylated in 5 high-grade chondrosarcomas and homozygously deleted in 1 chondrosarcoma. Moreover, a polymorphism was detected in 3 malignant tumours, but not in benign tumours or normal cartilage. Analysis of the p53 gene revealed an unchanged structure in all samples. These findings show a role for p16, but not p53, in chondrosarcoma. (C) 2000 Wiley-Liss, Inc.
Cite
CITATION STYLE
Asp, J., Sangiorgi, L., Inerot, S. E., Lindahl, A., Molendini, L., Benassi, M. S., & Picci, P. (2000). Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues. International Journal of Cancer, 85(6), 782–786. https://doi.org/10.1002/(SICI)1097-0215(20000315)85:6<782::AID-IJC7>3.0.CO;2-O
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.